A detailed history of Rhumbline Advisers transactions in Astrazeneca PLC stock. As of the latest transaction made, Rhumbline Advisers holds 26,134 shares of AZN stock, worth $1.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,134
Previous 26,743 2.28%
Holding current value
$1.69 Million
Previous $1.81 Million 12.53%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$66.81 - $80.83 $40,687 - $49,225
-609 Reduced 2.28%
26,134 $2.04 Million
Q1 2024

May 09, 2024

BUY
$61.03 - $69.57 $108,511 - $123,695
1,778 Added 7.12%
26,743 $1.81 Million
Q4 2023

Feb 08, 2024

BUY
$61.89 - $69.28 $38,062 - $42,607
615 Added 2.53%
24,965 $1.68 Million
Q3 2023

Nov 09, 2023

BUY
$64.85 - $71.7 $56,808 - $62,809
876 Added 3.73%
24,350 $1.65 Million
Q2 2023

Aug 08, 2023

BUY
$69.91 - $75.81 $1.64 Million - $1.78 Million
23,474 New
23,474 $1.68 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.